
April McClain Delaney
DHouseRepresentative · Maryland
T
Sold up to $15,000 of Bio-Techne (TECH)
Trade dated Mar 26, 202611 days to disclose
TECH since the sale
+0.9%
S&P 500, same window
+17.4%
▼ TECH trailed the S&P 500 by 16.5 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
⚑ Committee jurisdiction
April McClain Delaney sits on Research and Technology, which oversees the Healthcare sector. This trade fell in that sector while April McClain Delaney held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Mar 18, 2026LegislationHealthcare sector
- Mar 26, 2026TradeSold up to $15,000 of TECH
- Apr 6, 2026LegislationHealthcare sector
- Apr 6, 2026DisclosureDisclosed the tradePublic filing
- Apr 13, 2026LegislationHealthcare sector
- Apr 13, 2026LegislationHealthcare sector
- Apr 14, 2026LegislationHealthcare sector
- Apr 16, 2026Floor voteResult: Passed
- Apr 21, 2026Floor voteResult: Passed
- Apr 27, 2026Floor voteResult: Passed
- Apr 27, 2026Floor voteResult: Passed
- May 13, 2026Floor voteResult: Passed
- May 20, 2026CommitteeFull Committee Markup
- Jun 4, 2026Committee"For the Purpose of Receiving Testimony from the Honorable Brooke L. Rollins, Secretary, U.S. Department of Agriculture"
- Jun 10, 2026Committee"Agricultural Perspectives on the Future of the USMCA"
Get an alert the moment April McClain Delaney files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.